Nuvation Bio Inc
NYSE:NUVB
Nuvation Bio Inc
NYSE:NUVB
Price:
5.64
USD
3.3%
Market Closed
Market Cap:
$1.9B
Income Statement
Earnings Waterfall
Nuvation Bio Inc
Nuvation Bio Inc
Income Statement
Nuvation Bio Inc
Nuvation Bio Inc
Currency: USD
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
7
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
N/A
|
2
+51%
|
8
+264%
|
11
+39%
|
14
+31%
|
27
+86%
|
|
| Gross Profit | ||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(7)
|
(9)
|
(10)
|
(12)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(1)
N/A
|
1
N/A
|
2
+125%
|
4
+122%
|
15
+267%
|
|
| Operating Income | ||||||||||||||||||||||
| Operating Expenses |
(40)
|
(44)
|
(55)
|
(66)
|
(77)
|
(93)
|
(101)
|
(118)
|
(125)
|
(112)
|
(118)
|
(106)
|
(103)
|
(100)
|
(94)
|
(113)
|
(134)
|
(168)
|
(633)
|
(229)
|
(247)
|
|
| Selling, General & Administrative |
(8)
|
(11)
|
(14)
|
(18)
|
(21)
|
(24)
|
(27)
|
(30)
|
(32)
|
(32)
|
(32)
|
(31)
|
(30)
|
(29)
|
(28)
|
(37)
|
(49)
|
(69)
|
(97)
|
(120)
|
(137)
|
|
| Research & Development |
(32)
|
(33)
|
(41)
|
(48)
|
(56)
|
(69)
|
(74)
|
(89)
|
(93)
|
(81)
|
(79)
|
(68)
|
(66)
|
(71)
|
(65)
|
(76)
|
(85)
|
(99)
|
(111)
|
(109)
|
(110)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
(7)
|
(7)
|
0
|
0
|
0
|
0
|
0
|
(425)
|
0
|
0
|
|
| Operating Income |
(40)
N/A
|
(44)
-8%
|
(55)
-26%
|
(66)
-21%
|
(77)
-17%
|
(93)
-20%
|
(101)
-8%
|
(118)
-17%
|
(125)
-6%
|
(112)
+10%
|
(118)
-5%
|
(106)
+10%
|
(103)
+3%
|
(100)
+3%
|
(94)
+6%
|
(113)
-21%
|
(134)
-19%
|
(168)
-25%
|
(631)
-277%
|
(225)
+64%
|
(233)
-4%
|
|
| Pre-Tax Income | ||||||||||||||||||||||
| Interest Income Expense |
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
6
|
10
|
16
|
21
|
24
|
27
|
28
|
28
|
27
|
25
|
22
|
15
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
0
|
0
|
(425)
|
(425)
|
(425)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
4
|
10
|
13
|
13
|
9
|
3
|
(0)
|
(0)
|
(0)
|
(2)
|
(1)
|
(1)
|
(2)
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(38)
N/A
|
(42)
-9%
|
(53)
-28%
|
(64)
-20%
|
(75)
-17%
|
(87)
-16%
|
(88)
-1%
|
(103)
-18%
|
(108)
-5%
|
(104)
+4%
|
(105)
0%
|
(90)
+14%
|
(83)
+8%
|
(76)
+9%
|
(69)
+9%
|
(511)
-642%
|
(532)
-4%
|
(568)
-7%
|
(606)
-7%
|
(203)
+67%
|
(217)
-7%
|
|
| Net Income | ||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(38)
|
(42)
|
(53)
|
(64)
|
(75)
|
(87)
|
(88)
|
(103)
|
(108)
|
(104)
|
(105)
|
(90)
|
(83)
|
(76)
|
(69)
|
(511)
|
(532)
|
(568)
|
(606)
|
(203)
|
(217)
|
|
| Net Income (Common) |
(38)
N/A
|
(64)
-67%
|
(76)
-18%
|
(87)
-14%
|
(98)
-13%
|
(87)
+11%
|
(88)
-1%
|
(103)
-18%
|
(108)
-5%
|
(104)
+4%
|
(105)
0%
|
(90)
+14%
|
(83)
+8%
|
(76)
+9%
|
(69)
+9%
|
(511)
-642%
|
(532)
-4%
|
(568)
-7%
|
(606)
-7%
|
(203)
+67%
|
(217)
-7%
|
|
| EPS (Diluted) |
-0.18
N/A
|
-0.3
-67%
|
-0.44
-47%
|
-0.42
+5%
|
-0.48
-14%
|
-0.44
+8%
|
-0.42
+5%
|
-0.49
-17%
|
-0.5
-2%
|
-0.48
+4%
|
-0.48
N/A
|
-0.41
+15%
|
-0.38
+7%
|
-0.35
+8%
|
-0.31
+11%
|
-2.08
-571%
|
-1.94
+7%
|
-2.11
-9%
|
-1.79
+15%
|
-0.59
+67%
|
-0.64
-8%
|
|
Switch to:
Switch to:
See Also
Discover More
